Table 1.

Longitudinal T-LGLL characteristics of patients with leukemia

STAT3MTHematologic presentationAAD, ySexTherapyLGL count*Flow cytometryTCR deep sequencing
VB IDClone size*, %Major clonotype(s)Clone size*, %Clonal diversity*,Clonality*,
CCF1 D661V Anemia 68 CSA, CYC, MTX 2455 NIP 65 CASSLLAGGYNEQFF 42 0.176 0.373 
CCF2 D661V Neutropenia thrombocytopenia 81 MTX 1225 TRBV9 72 CASSVGQGSPLHF 75 0.565 0.734 
CCF3 Y640F Neutropenia thrombocytopenia 55 CSA 1355 TRBV6-2, TRBV3-1 25, 16 CASSLASISYNEQFF 26 0.068 0.263 
CCF4 D661Y, Y640F Pancytopenia 64 CSA, MTX 3672 TRBV10-3 23 CASSAPREGTAYEQYF, CASSPTSGGEQFF 8, 5 0.016 0.222 
CCF5 D661Y Anemia, neutropenia 54 CSA, CYC 10 631 TRBV9 99 CASSVGRFQETQYF 44 0.192 0.378 
CCF6 Y640F Neutropenia 47 CSA, CYC, MTX 850 TRBV29-1 8, 11 CASSTFAEIRQPQHF, CASSLTENYGYTF 4, 0.01 0.002 0.046 
CCF7 D661Y Neutropenia 40 CSA, CYC, MTX 2882 NIP 95 CATSRGTGDSYEQYF 97 0.934 0.938 
CCF8 Y640F Anemia, neutropenia 37 CSA 480 TRBV12-3, TRBV12-4 82 CASSSLTGLPPYEQYF 29 0.085 0.247 
CCF9 Y640F Anemia, neutropenia 74 CSA, CYC, MTX 496 NIP 96 CASSPEGFQPQHF, CASTSFGTGTDTQYF 91, 0.16 0.819 0.871 
CCF10 Negative Anemia, neutropenia 17 CSA, MTX 330 TRBV18 77 CASSPFWTLEKLFF 93 0.871 0.893 
CCF11 Negative Anemia 63 CSA, CYC, MTX 980 TRVB28, TRBV19 32, 18 CASSPLGAVGYNEQFF, CAISEFPGGQTSDEGFF 25, 1 0.086 0.471 
CCF12 Negative Neutropenia 47 CSA, MTX 188 TRBV12-3, TRBV12-4 45 CASSIAGLGSEQFF, CASSEGQMYNEQFF 12, 3 0.019 0.191 
CCF13 Negative Anemia, neutropenia 52 CSA, CYC, MTX 261 TRBV13 97 CASSDLAGMLGRQFF 99 0.983 0.984 
CCF14 Negative Anemia 66 CYC 409 NIP, TRBV20-1 84, 24 CASSLEIAGGLIYNEQFF, CASSPGLAGGRETQYF 27, 2 0.093 0.350 
CCF15 Negative Anemia, neutropenia 60 CSA, CYC, MDX 4472 TRBV19 97 CASSIGIQPQHF 83 0.686 0.791 
CCF16 Negative Asymptomatic 59 SCT, CYC 1515 TRBV27 30 CASSSVGYEQYF 40 0.173 0.478 
CCF17 Negative Anemia 71 MTX 2536 TRBV19 20 CASRASGSDEQYF, CARSRDKGTDYGYTF 10, 8 0.024 0.263 
CCF18 Negative Asymptomatic 54 None 686 TRBV27, TRVB4-3 12, 8 CASSLGNYEQYF, CASSISQNTEAFF 4, 7 0.026 0.319 
STAT3MTHematologic presentationAAD, ySexTherapyLGL count*Flow cytometryTCR deep sequencing
VB IDClone size*, %Major clonotype(s)Clone size*, %Clonal diversity*,Clonality*,
CCF1 D661V Anemia 68 CSA, CYC, MTX 2455 NIP 65 CASSLLAGGYNEQFF 42 0.176 0.373 
CCF2 D661V Neutropenia thrombocytopenia 81 MTX 1225 TRBV9 72 CASSVGQGSPLHF 75 0.565 0.734 
CCF3 Y640F Neutropenia thrombocytopenia 55 CSA 1355 TRBV6-2, TRBV3-1 25, 16 CASSLASISYNEQFF 26 0.068 0.263 
CCF4 D661Y, Y640F Pancytopenia 64 CSA, MTX 3672 TRBV10-3 23 CASSAPREGTAYEQYF, CASSPTSGGEQFF 8, 5 0.016 0.222 
CCF5 D661Y Anemia, neutropenia 54 CSA, CYC 10 631 TRBV9 99 CASSVGRFQETQYF 44 0.192 0.378 
CCF6 Y640F Neutropenia 47 CSA, CYC, MTX 850 TRBV29-1 8, 11 CASSTFAEIRQPQHF, CASSLTENYGYTF 4, 0.01 0.002 0.046 
CCF7 D661Y Neutropenia 40 CSA, CYC, MTX 2882 NIP 95 CATSRGTGDSYEQYF 97 0.934 0.938 
CCF8 Y640F Anemia, neutropenia 37 CSA 480 TRBV12-3, TRBV12-4 82 CASSSLTGLPPYEQYF 29 0.085 0.247 
CCF9 Y640F Anemia, neutropenia 74 CSA, CYC, MTX 496 NIP 96 CASSPEGFQPQHF, CASTSFGTGTDTQYF 91, 0.16 0.819 0.871 
CCF10 Negative Anemia, neutropenia 17 CSA, MTX 330 TRBV18 77 CASSPFWTLEKLFF 93 0.871 0.893 
CCF11 Negative Anemia 63 CSA, CYC, MTX 980 TRVB28, TRBV19 32, 18 CASSPLGAVGYNEQFF, CAISEFPGGQTSDEGFF 25, 1 0.086 0.471 
CCF12 Negative Neutropenia 47 CSA, MTX 188 TRBV12-3, TRBV12-4 45 CASSIAGLGSEQFF, CASSEGQMYNEQFF 12, 3 0.019 0.191 
CCF13 Negative Anemia, neutropenia 52 CSA, CYC, MTX 261 TRBV13 97 CASSDLAGMLGRQFF 99 0.983 0.984 
CCF14 Negative Anemia 66 CYC 409 NIP, TRBV20-1 84, 24 CASSLEIAGGLIYNEQFF, CASSPGLAGGRETQYF 27, 2 0.093 0.350 
CCF15 Negative Anemia, neutropenia 60 CSA, CYC, MDX 4472 TRBV19 97 CASSIGIQPQHF 83 0.686 0.791 
CCF16 Negative Asymptomatic 59 SCT, CYC 1515 TRBV27 30 CASSSVGYEQYF 40 0.173 0.478 
CCF17 Negative Anemia 71 MTX 2536 TRBV19 20 CASRASGSDEQYF, CARSRDKGTDYGYTF 10, 8 0.024 0.263 
CCF18 Negative Asymptomatic 54 None 686 TRBV27, TRVB4-3 12, 8 CASSLGNYEQYF, CASSISQNTEAFF 4, 7 0.026 0.319 

AAD, age at diagnosis; CSA, cyclosporine-A; CYC, cyclophosphamide; F, female; FU, follow-up; M, male; MTX, methotrexate; SCT, stem cell transplant.

*At earliest sampling.

†Clonal diversity and Clonality assessed according to Clemente et al.9

Close Modal

or Create an Account

Close Modal
Close Modal